These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 31076803)
1. Letter to the Editor : Comment on 'Use of an in vitro-in silico testing strategy to predict inter-species and inter-ethnic human differences in liver toxicity of the pyrrolizidine alkaloids lasiocarpine and riddelliine' by Ning et al., Arch Toxicol doi: https://doi.org/10.1007/s00204-019-02397-7. Mielke H; Partosch F; Gundert-Remy U Arch Toxicol; 2019 May; 93(5):1465-1466. PubMed ID: 31076803 [No Abstract] [Full Text] [Related]
2. Selecting the dose metric in reverse dosimetry based QIVIVE : Reply to 'Comment on 'Use of an in vitro-in silico testing strategy to predict inter-species and inter-ethnic human differences in liver toxicity of the pyrrolizidine alkaloids lasiocarpine and riddelliine' by Ning et al., Arch Toxicol doi: https://doi.org/10.1007/s00204-019-02397-7', Arch Toxicol doi: https://doi.org/10.1007/s0020 4-019-02421-w. Rietjens IMCM; Ning J; Chen L; Wesseling S; Strikwold M; Louisse J Arch Toxicol; 2019 May; 93(5):1467-1469. PubMed ID: 31062055 [No Abstract] [Full Text] [Related]
3. Use of an in vitro-in silico testing strategy to predict inter-species and inter-ethnic human differences in liver toxicity of the pyrrolizidine alkaloids lasiocarpine and riddelliine. Ning J; Chen L; Strikwold M; Louisse J; Wesseling S; Rietjens IMCM Arch Toxicol; 2019 Mar; 93(3):801-818. PubMed ID: 30661089 [TBL] [Abstract][Full Text] [Related]
4. Use of physiologically based kinetic modelling-facilitated reverse dosimetry to convert in vitro cytotoxicity data to predicted in vivo liver toxicity of lasiocarpine and riddelliine in rat. Chen L; Ning J; Louisse J; Wesseling S; Rietjens IMCM Food Chem Toxicol; 2018 Jun; 116(Pt B):216-226. PubMed ID: 29634986 [TBL] [Abstract][Full Text] [Related]
5. Prediction of in vivo genotoxicity of lasiocarpine and riddelliine in rat liver using a combined in vitro-physiologically based kinetic modelling-facilitated reverse dosimetry approach. Chen L; Peijnenburg A; de Haan L; Rietjens IMCM Arch Toxicol; 2019 Aug; 93(8):2385-2395. PubMed ID: 31289892 [TBL] [Abstract][Full Text] [Related]
6. Integrating physiologically based kinetic (PBK) and Monte Carlo modelling to predict inter-individual and inter-ethnic variation in bioactivation and liver toxicity of lasiocarpine. Ning J; Rietjens IMCM; Strikwold M Arch Toxicol; 2019 Oct; 93(10):2943-2960. PubMed ID: 31511935 [TBL] [Abstract][Full Text] [Related]
7. Pyrrolizidine alkaloid-derived DNA adducts as a common biological biomarker of pyrrolizidine alkaloid-induced tumorigenicity. Xia Q; Zhao Y; Von Tungeln LS; Doerge DR; Lin G; Cai L; Fu PP Chem Res Toxicol; 2013 Sep; 26(9):1384-96. PubMed ID: 23937665 [TBL] [Abstract][Full Text] [Related]
8. Role of toxicokinetics and alternative testing strategies in pyrrolizidine alkaloid toxicity and risk assessment; state-of-the-art and future perspectives. Ning J; Chen L; Rietjens IMCM Food Chem Toxicol; 2019 Sep; 131():110572. PubMed ID: 31185270 [TBL] [Abstract][Full Text] [Related]
9. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid. Wang YP; Yan J; Fu PP; Chou MW Toxicol Lett; 2005 Mar; 155(3):411-20. PubMed ID: 15649625 [TBL] [Abstract][Full Text] [Related]
10. Monocrotaline-induced liver toxicity in rat predicted by a combined in vitro physiologically based kinetic modeling approach. Suparmi S; Wesseling S; Rietjens IMCM Arch Toxicol; 2020 Sep; 94(9):3281-3295. PubMed ID: 32518961 [TBL] [Abstract][Full Text] [Related]
11. Development of enzyme-linked immunosorbent assays for the hepatotoxic alkaloids riddelliine and riddelliine N-oxide. Lee ST; Schoch TK; Stegelmeier BL; Gardner DR; Than KA; Molyneux RJ J Agric Food Chem; 2001 Aug; 49(8):4144-51. PubMed ID: 11513723 [TBL] [Abstract][Full Text] [Related]
12. Response to letter to the editor from Dr Rahman Shiri: The challenging topic of suicide across occupational groups. Niedhammer I; Milner A; Witt K; Klingelschmidt J; Khireddine-Medouni I; Alexopoulos EC; Toivanen S; Chastang JF; LaMontagne AD Scand J Work Environ Health; 2018 Jan; 44(1):108-110. PubMed ID: 29218357 [TBL] [Abstract][Full Text] [Related]
13. Opinion letter regarding the article Arch Toxicol https://doi.org/10.1007/s00204-018-2240-x. Brozovic A Arch Toxicol; 2018 Oct; 92(10):3241. PubMed ID: 30039230 [No Abstract] [Full Text] [Related]
14. Development of an in vitro screening method of acute cytotoxicity of the pyrrolizidine alkaloid lasiocarpine in human and rodent hepatic cell lines by increasing susceptibility. Forsch K; Schöning V; Disch L; Siewert B; Unger M; Drewe J J Ethnopharmacol; 2018 May; 217():134-139. PubMed ID: 29454024 [TBL] [Abstract][Full Text] [Related]
15. Toxicity of pyrrolizidine alkaloids from Riddell groundsel (Senecio riddellii) to cattle. Molyneux RJ; Johnson AE; Olsen JD; Baker DC Am J Vet Res; 1991 Jan; 52(1):146-51. PubMed ID: 2021243 [TBL] [Abstract][Full Text] [Related]
16. An in vitro comparison of the cytotoxic potential of selected dehydropyrrolizidine alkaloids and some N-oxides. Field RA; Stegelmeier BL; Colegate SM; Brown AW; Green BT Toxicon; 2015 Apr; 97():36-45. PubMed ID: 25666399 [TBL] [Abstract][Full Text] [Related]
17. Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, heliotrine. Xia Q; Yan J; Chou MW; Fu PP Toxicol Lett; 2008 May; 178(2):77-82. PubMed ID: 18395999 [TBL] [Abstract][Full Text] [Related]
18. Initiation and selection of resistant hepatocyte nodules in rats given the pyrrolizidine alkaloids lasiocarpine and senecionine. Hayes MA; Roberts E; Farber E Cancer Res; 1985 Aug; 45(8):3726-34. PubMed ID: 2861891 [TBL] [Abstract][Full Text] [Related]